Abstract

BackgroundLaryngeal squamous cell carcinoma (LSCC) is considered to be a common malignancy of the head and neck with poor prognosis for its late diagnosis, metastasis and recurrence. Growing evidence demonstrates that the dysregulation of miR-29c-3p (microRNA-29c-3p) plays an important role in various tumor processes. Our study investigates the expression of miR-29c-3p in LSCC and analyzes the correlation of its dysregulation with clinicopathologic parameters and prognosis.MethodsThe expression of hsa-miR-29c-3p in LSCC tissues and the adjacent normal laryngeal tissues was detected in 96 LSCC formalin-fixed paraffin-embedded tissues by quantitative real-time PCR (qRT-PCR). The SPSS statistical software package (17.0) was used to analyze the associations between miR-29c-3p expressions and various clinicopathological characteristics. The overall survival (OS) was analyzed by the Kaplan-Meier method and log-rank test, and we analyzed the independent factor of prognosis by Cox proportional hazard analysis.ResultsA downregulation of miR-29c-3p expression in LSCC was significantly correlated with smoking index, tumor size, tumor site, differentiation, T classification, TNM stage, and lymph node metastasis (P < 0.05), but there was no correlation with age and alcohol consumption (P > 0.05). In the multivariate survival analysis, low miR-29c-3p expression was associated with shorter overall survival (P < 0.05). Furthermore, miR-29c expression was an independent prognostic factor for laryngeal cancer patients.ConclusionsMiR-29c-3p has different expression levels at different stages of tumor progression, suggesting that miR-29c-3p may be a promising biomarker for evaluating the progression of LSCC and the prognosis of patients with LSCC. MiR-29c-3p can also be a novel molecular target for anti-laryngeal cancer therapy.

Highlights

  • Laryngeal squamous cell carcinoma (LSCC), as the most common histopathological type of laryngeal cancer, is the second-most common malignancy of the head and neck [1, 2].According to studies, almost 3650 people died from LSCC worldwide in 2012, concomitantly with the increasing incidence and mortality of LSCC year-by-year [3]

  • Downregulation of miR-29c in LSCC The results of quantitative real-time PCR (qRT-PCR) showed that the relative expression level of miR-29c in the 66 patients with LSCC was miR-29c-3p expression (X Æ S)

  • Our results indicated that low level expression of miR-29c correlates with smoking index≥400, which implied that miR-29c might be involved in the pathomechanism of cigarettes inducing laryngeal cancer

Read more

Summary

Introduction

Laryngeal squamous cell carcinoma (LSCC), as the most common histopathological type of laryngeal cancer, is the second-most common malignancy of the head and neck [1, 2].According to studies, almost 3650 people died from LSCC worldwide in 2012, concomitantly with the increasing incidence and mortality of LSCC year-by-year [3]. MiRNAs play important roles in all tumor-related processes, including proliferation, differentiation, apoptosis, metastasis, invasion and angiogenesis in LSCC. MiR-29c-3p, as a tumor suppressor in the miRNAs family [9], has been demonstrated to be downregulated in many solid tumors, such as nasopharyngeal carcinoma [10], gastric cancer [11], hepatocellular carcinoma [12], gallbladder cancer [13], esophageal cancer [14], breast cancer [15], colon cancer [16] and head and neck cancers [17], which revealed that lower expression of miR-29c was associated with lymph node metastasis, tumor differentiation, TNM stage and poor prognosis. Laryngeal squamous cell carcinoma (LSCC) is considered to be a common malignancy of the head and neck with poor prognosis for its late diagnosis, metastasis and recurrence. Our study investigates the expression of miR-29c-3p in LSCC and analyzes the correlation of its dysregulation with clinicopathologic parameters and prognosis

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.